An interventional study of Neurodynamic mobilization and Carpal bone mobilization in Carpal Tunnel Syndrome and Splints, sponsored by Kutahya Health Sciences University. Not yet recruiting at 1 site in Turkey (Türkiye). Open to participants aged 20 Years to 55 Years. Per ClinicalTrials.gov, last updated 2026-01-22.
Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 130 studies in Carpal Tunnel Syndrome with a site in Turkey — 36 open to participants now, 41 under way, none of them phase 3. Carpal Tunnel Syndrome · Turkey.
Among the 130 studies in Carpal Tunnel Syndrome with a site in Turkey, this one is the 10th largest by planned enrollment of the 82 interventional ones that give a count, is one of 20 that started in 2026, is one of 75 with no phase, reaches primary completion later than 31 of the 40 other live ones, and was the 106th registered.
591 studies on the registry are indexed under Carpal Tunnel Syndrome; 133 are open to participants now.
Browse Carpal Tunnel Syndrome studies →36 of the 130 studies in Carpal Tunnel Syndrome with a site in Turkey are open now. Recruiting first, the newest first:
Izmir Bakircay University · Sites in Turkey
Ages 18–60
Izmir Bakircay University · Sites in Turkey
Ages 18–60
Konya Beyhekim Training and Research Hospital · Sites in Turkey
Ages 18–65 · Healthy volunteers
Haydarpasa Numune Training and Research Hospital · Sites in Turkey
Ages 18–75
Istanbul University · Sites in Turkey
Ages 18–65
A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →
Of the 72 Carpal Tunnel Syndrome studies recruiting now, 27 (38%) set no upper age limit and 36 (50%) stop at 75 or younger; 1 takes children under 18; 11 take healthy volunteers.
This study: 20 Years to 55 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
130 studies; the count open now beside each. This study's row is marked.
First in 2011; this study’s year is marked. 20 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 93 is above the median of 60 across 446 interventional studies indexed under Carpal Tunnel Syndrome.
Median enrollment 60 across the 82 interventional studies, 84 across the 48 observational. Of the 82 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 130 has an industry lead sponsor. The 10 most frequent:
Kutahya Health Sciences University is the lead sponsor of 219 studies on the registry; 48 are open to participants now.
Kutahya Health Sciences University has 8 studies filed under Carpal Tunnel Syndrome — fewer than ten, so there is no comparison to draw.
12 of the studies in Carpal Tunnel Syndrome with a site in Turkey that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07433166SB Istanbul Education and Research HospitalUltrasound Evaluation in Carpal Tunnel Syndrome | 2026-12 |
| NCT07327723Ankara UniversityEffects of Repetitive Peripheral Magnetic Stimulation(rPMS) on CTS(Carpal Tunnel Syndrome) | 2026-12-15 |
| NCT07522060Hacettepe UniversityEarly Functional Response as a Predictor of Clinical Outcomes in Hand Rehabilitation: A Prospective Feasibility Study Using a Digital Monitoring System | 2026-12-30 |
| NCT07847450Bezmialem Vakif UniversityMeasurement of Muscle Strength Using a Manual Muscle Tester in Women With Electrophysiologically Confirmed Carpal Tunnel Syndrome | 2027-01 |
| NCT07359274Kutahya Health Sciences UniversityEffects of Neurodynamic and Carpal Bone Mobilization in Mild-to-Moderate Carpal Tunnel Syndrome | 2027-01-15 |
Add all 12 to your calendar (.ics) → With an account.
Among the 130 studies in Carpal Tunnel Syndrome with a site in Turkey, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Carpal tunnel syndrome (CTS) is the most common entrapment neuropathy caused by compression of the median nerve at the wrist. Conservative interventions such as splinting and manual therapy are frequently used in individuals with mild-to-moderate CTS. Neurodynamic mobilization and carpal bone mobilization aim to improve neural and soft tissue mobility; however, their comparative effects on clinical outcomes and median nerve morphology are not fully understood.
This interventional, non-randomized clinical study aims to compare the clinical and ultrasonographic effects of neurodynamic mobilization plus splinting, carpal bone mobilization plus splinting, and splinting alone in patients with mild-to-moderate CTS. Ninety-three participants diagnosed with mild-to-moderate carpal tunnel syndrome based on electrodiagnostic criteria will be included. Participants will be allocated into three parallel groups without randomization. All participants will receive a neutral-position wrist splint as standard conservative care.
Two intervention groups will additionally receive either neurodynamic mobilization exercises or carpal bone mobilization techniques administered by a physiotherapist for four weeks. Clinical outcomes and median nerve morphology will be evaluated at baseline and immediately after the intervention period.
The primary outcome is the change in the Boston Carpal Tunnel Questionnaire score. Secondary outcomes include pain intensity, neuropathic pain, functional disability, muscle strength, pressure pain threshold, and ultrasonographic measurements of the median nerve.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Median nerve neurodynamic mobilization exercises administered by a physiotherapist for 4 weeks in addition to night-time wrist splint use
Other: Neurodynamic mobilization · Other: Splint
Carpal bone mobilization techniques administered by a physiotherapist for 4 weeks in addition to night-time wrist splint use.
Other: Carpal bone mobilization · Other: Splint
Neutral-position wrist splint worn at night for 4 weeks.
Other: Splint
Median nerve neurodynamic mobilization exercises performed 5 sessions per week for 4 weeks.
Manual carpal bone mobilization techniques applied 5 sessions per week for 4 weeks.
Neutral-position wrist splint used during night-time for 4 weeks.
Boston Carpal Tunnel Questionnaire (BCTQ) Total Score
Change in Boston Carpal Tunnel Questionnaire (BCTQ) Total Score
Time frame: Baseline to 4 weeks
Visual Analog Scale (VAS)
Pain intensity measured using a 10-cm visual analog scale.
Time frame: Baseline to 4 weeks
Leeds Assessment of Neuropathic Symptoms and Signs (LANSS)
Change in Neuropathic Pain Score Assessed by Leeds Assessment of Neuropathic Symptoms and Signs (LANSS).
Time frame: Baseline to 4 weeks
Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH)
Change in Upper Extremity Disability Assessed by Quick Disabilities of the Arm, Shoulder and Hand (QuickDASH).
Time frame: Baseline to 4 weeks
Grip Strength
Change Grip strength measured using a Jamar dynamometer.
Time frame: Baseline to 4 weeks
Pinch Strength
Change in Pinch Strength measured using a Pinchmeter.
Time frame: Baseline to 4 weeks
Pressure Pain Threshold
Change in pressure pain threshold assessed using J -Tech algometer.
Time frame: Baseline to 4 weeks
Median Nerve Cross-Sectional Area
Change in Median Nerve Cross-Sectional Area Assessed by Ultrasonography.
Time frame: Baseline to 4 weeks
Plan to share: No
No publications or documents are linked to this record.
Start is estimated for Jan 2026; primary completion for Jan 2027, 12 months later.
Of 252 non-industry interventional studies with no phase under Carpal Tunnel Syndrome, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 7 and three quarters within 27. This study's planned 12 months is close to that.
Counting every sponsor, half of 262 studies reached it within 12 months; a quarter within 7 and three quarters within 26.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Kutahya Health Sciences University →